10-K/A XBRL

FORM 10-K/A

Company: GYRE THERAPEUTICS, INC.
Filed: May 2, 2022
Period of Report: December 31, 2021
Accession Number: 0001193125-22-136435

View Document ↗ View on SEC.gov ↗